A Multicenter, Double-Blind, Randomized, and Placebo-controlled Phase Ib Study Evaluating the Safety of Adding Tocilizumab to Standard Premedications Prior to Administration of Obinutuzumab in Combination With Chlorambucil in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia and Comorbidities
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2017
At a glance
- Drugs Tocilizumab (Primary) ; Chlorambucil; Obinutuzumab
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- Sponsors Roche
- 21 Aug 2017 Planned End Date changed from 23 Mar 2018 to 27 Mar 2019.
- 21 Aug 2017 Planned primary completion date changed from 23 Mar 2018 to 27 Mar 2019.
- 25 May 2017 Planned End Date changed from 31 Mar 2018 to 23 Mar 2018.